March 2, 2018 Tolerance induction in HLA disparate living donor kidney transplantation by facilitating cell-enriched donor stem cell Infusion: The importance of durable chimerism Human Immunology Joseph R. Leventhal, Suzanne T. Ildstad

November 1, 2017 HSCT-Based Approaches for Tolerance Induction in Renal Transplant Transplantation Journal Anita Chhabra, Joseph Leventhal, Andrea Merchak, Suzanne Ildstad

November 9, 2015 Characterization of human CD8+TCR- facilitating cells in vitro and in vivo in a NOD/SCID/IL2rγnull mouse model American Journal of Transplantation Y. Huang, M. J. Elliott, E. S. Yolcu, T. O. Miller, J. Ratajczak, L. D. Bozulic, Y. Wen, H. Xu, M. Z. Ratajczak, and S. T. Ildstad

February 1, 2015 Immune Reconstitution/Immunocompetence in Recipients of Kidney Plus Hematopoietic Stem/Facilitating Cell Transplants Transplantation Journal Joseph Leventhal, Mary Elliott, Esma Yolcu, Larry Bozulic, David Tollerud, James Mathew, Iwona Konieczna, Michael Ison, John Galvin, Jayesh Mehta, Mark Badder, Michael M. Abecassis, Joshua Miller, Lorenzo Gallon, Suzanne Ildstad

January 15, 2013 Tolerance Induction in HLA Disparate Living Donor Kidney Transplantation by Donor Stem Cell Infusion: durable chimerism predicts outcome Transplantation Journal Joseph Leventhal, Michael Abecassis, Joshua Miller, Lorenzo Gallon, David Tollerud, Mary Jane Elliott, Larry D. Bozulic, Chris Houston, Nedjema Sustento-Reodica, and Suzanne T. Ildstad

March 7, 2012 The Quest for Transplantation Tolerance: Have We Finally Sipped from the Cup? Science Translational Medicine James F. Markmann and Tatsuo Kawai

March 7, 2012 Chimerism and Tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation Science Translational Medicine Joseph Leventhal, Michael Abecassis, Joshua Miller, Lorenzo Gallon, Kadiyala Ravindra, David J. Tollerud, Bradley King, Mary Jane Elliott, Geoffrey Herzig, Roger Herzig, and Suzanne T. Ildstad



If you are a health care provider and would like to receive more information about our clinical trials, please email

If you are a patient and would like to receive more information about our clinical trials, please email